Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Lesaka Technologies (NASDAQ:LSAK) Fiscal Q1 2027 Earnings: Revenue USD 184.57M

Revenue was USD 184.57 million against USD 171.45 million a year earlier, an 8% increase in dollars. In rand, revenue was ZAR 3,005.68 million, a decrease of 0.6%, which the company linked to lower ADP revenue in Merchant and lower cash fees after exiting …

Nitish Kishor | 05 November 2026

American Bitcoin (NASDAQ:ABTC) Q3 Earnings: Net Income of USD 126.0M

Revenue came from Bitcoin rewards for computing services provided toMiningpool operators. The company mined approximately 891 Bitcoin, against approximately 563 a year earlier, helped by a full quarter of production from the Vega site, which added approximately 14.86 EH/s, and from the Drumheller site, …

Nitish Kishor | 05 November 2026

Acadia Pharmaceuticals (NASDAQ:ACAD) Q3 Earnings: Revenue of USD 342.29M

Total revenue guidance was revised to USD 1.265 billion to USD 1.295 billion, compared with a previous range of USD 1.24 billion to USD 1.30 billion. NUPLAZID net product sales were narrowed to USD 760 million to USD 775 million from USD 760 million …

Nitish Kishor | 05 November 2026

Acadia Healthcare (NASDAQ:ACHC) Q3 Results: USD 15.0M Sandoval Settlement Paid

The Sandoval matter followed aJuryjudgment that was affirmed in substantial part in April 2026. The company signed a settlement on May 31 with no admission of liability, and the USD 15.0 million payment was made in the third quarter.

Nitish Kishor | 05 November 2026

Ascent Industries (NASDAQ:ACNT) Q3 Earnings: Net Sales Reach USD 27.1M

Management attributed the 37.8% increase in net sales to a 17.4% increase in pounds shipped and a 21.1% increase in average selling prices. Excluding Midwest, net sales were USD 24.9 million, up 26.3%.

Nitish Kishor | 05 November 2026

ACRES Commercial Realty (NYSE:ACR) Reports Q3 Revenue of USD 24.22M

The chairman said the company now has three lines of business: principal investing,Investmentmanagement and insurance, with employees and directors owning over 45% of the common shares. Those lines arrived with new cost items.Mergerand internalization costs were USD 38.28 million, compensation and benefits were USD …

Nitish Kishor | 05 November 2026

Enact (NASDAQ:ACT) Raises 2026 Capital Return Guidance to About USD 600M

Net premiums earned were USD 242 million, against USD 245 million in both the second quarter of 2026 and the third quarter of 2025. The company said the change was driven mainly by higher ceded premiums from its continued use ofQuotashare reinsurance, partly offset …

Nitish Kishor | 05 November 2026

ADMA Biologics (NASDAQ:ADMA) Reports Q3 Gross Margin of 70.8% Against 56.3%

On March 2, 2026 the company borrowed USD 125.0 million under its revolvingFacilityand used it to fund an accelerated share repurchase agreement. It received an initial delivery of 6,422,608 shares and a further 4,337,879 shares when the agreement settled on May 7, 2026. Beyond …

Nitish Kishor | 05 November 2026

What Drove Adient (NYSE:ADNT) Fiscal Q4 Net Sales to USD 3.73B?

The debt actions carried one-time costs. A premium of USD 10 million on the debt repurchase, a USD 3 million write-off of deferred financing costs and USD 2 million of fees on TermLoanB modifications were each excluded from adjusted results. Net financing charges were …

Nitish Kishor | 05 November 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Q3 Results Show clonoSEQ Tests Delivered at 39,587

MRD revenue was USD 72.57 million against USD 56.79 million, a 28% increase. Service revenue was USD 72.57 million against USD 50.29 million, and the prior-year quarter also included USD 6.5 million of regulatory milestone revenue. The company tied the increase mainly to USD …

Nitish Kishor | 05 November 2026
Support

Hi! How can we help you today?

Loading…